Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson's disease therapy.

MLA

Alharthy, Khalid M., et al. “Neuroprotective Potential of Afzelin: A Novel Approach for Alleviating Catalepsy and Modulating Bcl-2 Expression in Parkinson’s Disease Therapy.” Saudi Pharmaceutical Journal, vol. 32, no. 2, Feb. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.jsps.2023.101928.

APA

Alharthy, K. M., Rashid, S., Yusufoglu, H. S., Alqasoumi, S. I., Ganaie, M. A., & Alam, A. (2024). Neuroprotective potential of Afzelin: A novel approach for alleviating catalepsy and modulating Bcl-2 expression in Parkinson’s disease therapy. Saudi Pharmaceutical Journal, 32(2), N.PAG. https://doi.org/10.1016/j.jsps.2023.101928

Chicago

Alharthy, Khalid M., Summya Rashid, Hasan S. Yusufoglu, Saleh I. Alqasoumi, Majid Ahmad Ganaie, and Aftab Alam. 2024. “Neuroprotective Potential of Afzelin: A Novel Approach for Alleviating Catalepsy and Modulating Bcl-2 Expression in Parkinson’s Disease Therapy.” Saudi Pharmaceutical Journal 32 (2): N.PAG. doi:10.1016/j.jsps.2023.101928.